Apple Watch feature becomes first digital health tech to receive this FDA approval

The FDA has granted the Apple Watch's atrial fibrillation (AFib) feature a landmark approval, making it the first digital health technology to qualify under the Medical Device Development Tools (MDDT) program. This feature, which detects abnormal heart patterns, can now be used in clinical studies to assess AFib burden. This approval elevates the Apple Watch's role in medical research, particularly for evaluating cardiac ablation devices.